Bill Text - HB572 (2021)

Relative to pharmacist administration of vaccines and allowing a licensed advanced pharmacy technician to administer vaccines.


Revision: May 13, 2021, 8:59 a.m.

Health and Human Services

May 13, 2021

2021-1464s

10/08

 

 

Amendment to HB 572

 

Amend the bill by replacing all after the enacting clause with the following:

 

1  Pharmacist Administration of Vaccines.  RSA 318:16-b is repealed and reenacted to read as follows:

318:16-b  Pharmacist Administration of Vaccines.  A pharmacist, pharmacy intern, or licensed advanced pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer influenza and a COVID-19 vaccine, if available, to the general public.  A pharmacist, pharmacy intern, or licensed advanced pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer haemophilus influenza, hepatitis A, hepatitis B, hepatitis A and B, human papillomavirus, meningococcal, pneumococcal, tetanus and diphtheria, varicella, zoster, MMR (measles, mumps, and rubella), and Tdap (tetanus, diphtheria and pertussis) vaccines, which have been approved by the Food and Drug Administration, to individuals 18 years of age or older as ordered by an immunizing pharmacist.  The pharmacist, pharmacy intern, or licensed advanced pharmacy technician shall:

I. Hold a current license to practice as a pharmacist, be registered as a pharmacy intern under RSA 318:15-b in New Hampshire, or be licensed as a licensed advanced pharmacy technician under RSA 318:15-c.

II. Possess at least $1,000,000 of professional liability insurance coverage.

III. In order to administer vaccines, have completed training specific to administration of the respective vaccines that includes programs approved by the Accreditation Council for Pharmacy Education (ACPE) or curriculum-based programs from an ACPE-accredited college of pharmacy or state or local health department programs or programs recognized by the board.

IV. Provide to the board evidence of compliance with paragraphs I-III.

V.  Provide notice to the primary care provider, when designated by the patient, of the administration of any vaccine.

VI. Record the vaccination in the state vaccine registry in accordance with RSA 141-C:20-f and/or when required by state and federal law and maintain a record of the vaccination as required by state and federal law.

VII.  Submit reports of any adverse reactions following vaccination to the Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System (VAERS).

2 Repeal.  RSA 318:16-d, relative to additional authority for pharmacist administration of vaccines, is repealed.

3  Effective Date.  This act shall take effect 90 days upon passage.

2021-1464s

AMENDED ANALYSIS

 

This bill allows licensed advanced pharmacy technicians to administer vaccines, combines the pharmacist administration of vaccines authority into one section, provides for recording vaccinations in the state vaccine registry, and requires the report of any adverse reactions.